|
Diabetes, Vol 47, Issue 3 482-486, Copyright © 1998 by American Diabetes Association
Shortened telomere length in white blood cells of patients with IDDM
E Jeanclos, A Krolewski, J Skurnick, M Kimura, H Aviv, JH Warram and A Aviv
Hypertension Research Center, Department of Preventive Medicine and Community Health, University of Medicine and Dentistry of New Jersey, Newark 07103-2714, USA.
IDDM is a polygenic and autoimmune disorder in which subsets of white blood
cells (WBCs) are engaged in the destruction of beta-cells of the pancreas.
The mechanisms that account for the abnormal behavior of these cells in
IDDM are not fully understood. By measuring the mean length of telomeres of
WBCs from patients with IDDM, we tested the concept that telomeres might
play a role in IDDM. We examined the lengths of the terminal restriction
fragments (TRFs) of DNA of WBCs from 234 white men comprising 54 patients
with IDDM, 74 patients with NIDDM, and 106 control subjects. When adjusted
for age, the TRF length from WBCs of patients with IDDM was significantly
shorter than that of nondiabetic control subjects (mean +/- SE: 8.6 +/- 0.1
vs. 9.2 +/- 0.1, P = 0.002). No significant difference was observed between
the TRF length from WBCs of patients with NIDDM versus nondiabetic
subjects. Neither the duration nor the complications of IDDM (i.e.,
nephropathy and hypertension) had an effect on the TRF length of WBCs from
patients with IDDM. The shortened TRF length of WBCs of patients with IDDM
likely reflects a marked reduction in the TRF length of subsets of WBCs
that play a role in the pathogenesis of IDDM.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N. Tentolouris, R. Nzietchueng, V. Cattan, G. Poitevin, P. Lacolley, A. Papazafiropoulou, D. Perrea, N. Katsilambros, and A. Benetos
White Blood Cells Telomere Length Is Shorter in Males With Type 2 Diabetes and Microalbuminuria
Diabetes Care,
November 1, 2007;
30(11):
2909 - 2915.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. C. Capell, F. S. Collins, and E. G. Nabel
Mechanisms of Cardiovascular Disease in Accelerated Aging Syndromes
Circ. Res.,
July 6, 2007;
101(1):
13 - 26.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Gardner, M. Kimura, W. Chai, J. F. Durrani, L. Tchakmakjian, X. Cao, X. Lu, G. Li, A. P. Peppas, J. Skurnick, et al.
Telomere Dynamics in Macaques and Humans
J. Gerontol. A Biol. Sci. Med. Sci.,
April 1, 2007;
62(4):
367 - 374.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Minamino and I. Komuro
Vascular Cell Senescence: Contribution to Atherosclerosis
Circ. Res.,
January 5, 2007;
100(1):
15 - 26.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Fitzpatrick, R. A. Kronmal, J. P. Gardner, B. M. Psaty, N. S. Jenny, R. P. Tracy, J. Walston, M. Kimura, and A. Aviv
Leukocyte Telomere Length and Cardiovascular Disease in the Cardiovascular Health Study
Am. J. Epidemiol.,
January 1, 2007;
165(1):
14 - 21.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Fuster and V. Andres
Telomere Biology and Cardiovascular Disease
Circ. Res.,
November 24, 2006;
99(11):
1167 - 1180.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Sampson, M. S. Winterbone, J. C. Hughes, N. Dozio, and D. A. Hughes
Monocyte Telomere Shortening and Oxidative DNA Damage in Type 2 Diabetes
Diabetes Care,
February 1, 2006;
29(2):
283 - 289.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S. Najjar, A. Scuteri, and E. G. Lakatta
Arterial Aging: Is It an Immutable Cardiovascular Risk Factor?
Hypertension,
September 1, 2005;
46(3):
454 - 462.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Gardner, S. Li, S. R. Srinivasan, W. Chen, M. Kimura, X. Lu, G. S. Berenson, and A. Aviv
Rise in Insulin Resistance Is Associated With Escalated Telomere Attrition
Circulation,
May 3, 2005;
111(17):
2171 - 2177.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Serrano and V. Andres
Telomeres and Cardiovascular Disease: Does Size Matter?
Circ. Res.,
March 19, 2004;
94(5):
575 - 584.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Brouilette, R. K. Singh, J. R. Thompson, A. H. Goodall, and N. J. Samani
White Cell Telomere Length and Risk of Premature Myocardial Infarction
Arterioscler. Thromb. Vasc. Biol.,
May 1, 2003;
23(5):
842 - 846.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Aviv
Hypothesis : Pulse Pressure and Human Longevity
Hypertension,
April 1, 2001;
37(4):
1060 - 1066.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Jeanclos, N. J. Schork, K. O. Kyvik, M. Kimura, J. H. Skurnick, and A. Aviv
Telomere Length Inversely Correlates With Pulse Pressure and Is Highly Familial
Hypertension,
August 1, 2000;
36(2):
195 - 200.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Engelhardt, K. Mackenzie, P. Drullinsky, R. T. Silver, and M. A. S. Moore
Telomerase Activity and Telomere Length in Acute and Chronic Leukemia, Pre- and Post-ex Vivo Culture
Cancer Res.,
February 1, 2000;
60(3):
610 - 617.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
N. Rufer, T. H. Brummendorf, S. Kolvraa, C. Bischoff, K. Christensen, L. Wadsworth, M. Schulzer, and P. M. Lansdorp
Telomere Fluorescence Measurements in Granulocytes and T Lymphocyte Subsets Point to a High Turnover of Hematopoietic Stem Cells and Memory T Cells in Early Childhood
J. Exp. Med.,
July 19, 1999;
190(2):
157 - 168.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1998 by the American Diabetes Association.
|
|
| |
|